Canessa PA - Search Results

1

Potential role of serum mesothelin in predicting survival of patients with malignant pleural mesothelioma.

Fontana V, Pistillo MP, Vigani A, Canessa PA, Berisso G, Giannoni U, Ferro P, Franceschini MC, Carosio R, Tonarelli M, Dessanti P, Roncella S. Fontana V, et al. Among authors: canessa pa. Oncol Lett. 2021 Feb;21(2):128. doi: 10.3892/ol.2020.12389. Epub 2020 Dec 18. Oncol Lett. 2021. PMID: 33552249 Free PMC article.

2

Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology.

Canessa PA, Franceschini MC, Ferro P, Battolla E, Dessanti P, Manta C, Sivori M, Pezzi R, Fontana V, Fedeli F, Pistillo MP, Roncella S. Canessa PA, et al. Cancer Invest. 2013 Jan;31(1):43-50. doi: 10.3109/07357907.2012.749265. Epub 2012 Dec 18. Cancer Invest. 2013. PMID: 23249166

3

Mesothelin is more useful in pleural effusion than in serum in the diagnosis of pleural mesothelioma.

Ferro P, Canessa PA, Battolla E, Dessanti P, Franceschini MC, Chiaffi L, Morabito A, Fontana V, Pezzi R, Fedeli F, Pistillo MP, Roncella S. Ferro P, et al. Among authors: canessa pa. Anticancer Res. 2013 Jun;33(6):2707-13. Anticancer Res. 2013. PMID: 23749930

4

Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology.

Franceschini MC, Ferro P, Canessa PA, Battolla E, Dessanti P, Valentino A, Casolari L, Fontana V, Pezzi R, Fedeli F, Pistillo MP, Roncella S. Franceschini MC, et al. Among authors: canessa pa. Anticancer Res. 2014 Dec;34(12):7425-9. Anticancer Res. 2014. PMID: 25503183

5

Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.

Battolla E, Canessa PA, Ferro P, Franceschini MC, Fontana V, Dessanti P, Pinelli V, Morabito A, Fedeli F, Pistillo MP, Roncella S. Battolla E, et al. Among authors: canessa pa. Anticancer Res. 2017 Mar;37(3):1387-1391. doi: 10.21873/anticanres.11460. Anticancer Res. 2017. PMID: 28314308

6

Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment.

Vigani A, Pistillo MP, Fontana V, Giannoni U, Rosenberg I, Canessa PA, Berisso G, Ferro P, Franceschini MC, Tonarelli M, Roncella S. Vigani A, et al. Among authors: canessa pa. J Thorac Oncol. 2018 Aug;13(8):e143-e145. doi: 10.1016/j.jtho.2018.03.015. J Thorac Oncol. 2018. PMID: 30049376 Free article. No abstract available.

7

The Correlation of Serum Mesothelin Level With Pleural Thickness in Malignant Pleural Mesothelioma Makes it a Valuable Tool for Monitoring Tumor Progression.

Fontana V, Vigani A, Pistillo MP, Giannoni U, Rosemberg I, Canessa PA, Berisso G, Ferro P, Franceschini MC, Tonarelli M, Roncella S. Fontana V, et al. Among authors: canessa pa. J Thorac Oncol. 2019 May;14(5):e92-e94. doi: 10.1016/j.jtho.2018.12.026. J Thorac Oncol. 2019. PMID: 31027749 Free article. No abstract available.

8

Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.

Fontana V, Pistillo MP, Vigani A, Canessa PA, Berisso G, Giannoni U, Ferro P, Franceschini MC, Carosio R, Tonarelli M, Rossi C, Dessanti P, Roncella S. Fontana V, et al. Among authors: canessa pa. Anticancer Res. 2019 Sep;39(9):5219-5223. doi: 10.21873/anticanres.13719. Anticancer Res. 2019. PMID: 31519636

9

Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis.

Carosio R, Fontana V, Mastracci L, Ferro P, Grillo F, Banelli B, Canessa PA, Dessanti P, Vigani A, Morabito A, Pfeffer U, Poggi A, Roncella S, Pistillo MP. Carosio R, et al. Among authors: canessa pa. J Cancer Res Clin Oncol. 2021 Feb;147(2):459-468. doi: 10.1007/s00432-020-03457-7. Epub 2020 Nov 20. J Cancer Res Clin Oncol. 2021. PMID: 33216211

10

Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma.

Dozin B, Carbotti G, Roncella S, Ferro P, Dessanti P, Canessa PA, Ferrini S, Fabbi M. Dozin B, et al. Among authors: canessa pa. Cancer Immunol Immunother. 2021 Nov;70(11):3349-3355. doi: 10.1007/s00262-021-02965-w. Epub 2021 May 18. Cancer Immunol Immunother. 2021. PMID: 34003301 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters